Evidence map›Paper›PMID 36581204›Full record

ArticleThe Journal of biological chemistry2023

Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants.

Ingrid Hartl, Veronika Brumovska, Yasmin Striedner, Atena Yasari, Gerhard J Schütz, Eva Sevcsik, Irene Tiemann-Boege

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ingrid HartlInstitute of Biophysics, Johannes Kepler University, Linz, Austria.
Veronika BrumovskaInsitute of Applied Physics, TU Wien, Vienna, Austria.
Yasmin StriednerInstitute of Biophysics, Johannes Kepler University, Linz, Austria.
Atena YasariInstitute of Biophysics, Johannes Kepler University, Linz, Austria.
Gerhard J SchützInsitute of Applied Physics, TU Wien, Vienna, Austria.
Eva SevcsikInsitute of Applied Physics, TU Wien, Vienna, Austria. Electronic address: eva.sevcsik@tuwien.ac.at.
Irene Tiemann-BoegeInstitute of Biophysics, Johannes Kepler University, Linz, Austria. Electronic address: irene.tiemann@jku.at.
Johannes Kepler University of Linz · ATTU Wien · AT

Funding

Austrian Science Fund FWF P 30867Austrian Science Fund FWF V 538
6 · The paper itself

Abstract

Fibroblast growth factor receptors (FGFRs) initiate signal transduction via the RAS/mitogen-activated protein kinase pathway by their tyrosine kinase activation known to determine cell growth, tissue differentiation, and apoptosis. Recently, many missense mutations have been reported for FGFR3, but we only know the functional effect for a handful of them. Some mutations result in aberrant FGFR3 signaling and are associated with various genetic disorders and oncogenic conditions. Here, we employed micropatterned surfaces to specifically enrich fluorophore-tagged FGFR3 (monomeric GFP [mGFP]-FGFR3) in certain areas of the plasma membrane of living cells. We quantified receptor activation via total internal reflection fluorescence microscopy of FGFR3 signaling at the cell membrane that captured the recruitment of the downstream signal transducer growth factor receptor-bound 2 (GRB2) tagged with mScarlet (GRB2-mScarlet) to FGFR3 micropatterns. With this system, we tested the activation of FGFR3 upon ligand addition (fgf1 and fgf2) for WT and four FGFR3 mutants associated with congenital disorders (G380R, Y373C, K650Q, and K650E). Our data showed that ligand addition increased GRB2 recruitment to WT FGFR3, with fgf1 having a stronger effect than fgf2. For all mutants, we found an increased basal receptor activity, and only for two of the four mutants (G380R and K650Q), activity was further increased upon ligand addition. Compared with previous reports, two mutant receptors (K650Q and K650E) had either an unexpectedly high or low activation state, respectively. This can be attributed to the different methodology, since micropatterning specifically captures signaling events at the plasma membrane. Collectively, our results provide further insight into the functional effects of mutations to FGFR3.

Indexed as

Cell MembraneGRB2 Adaptor ProteinReceptor, Fibroblast Growth Factor, Type 3Fibroblast Growth Factor 1Fibroblast Growth Factor 2LigandsMicroscopy, FluorescenceSignal TransductionFibroblast Growth Factor 1Fibroblast Growth Factor 2GRB2 Adaptor ProteinLigandsReceptor, Fibroblast Growth Factor, Type 3FGFR3fibroblast growth factorGRB2receptor tyrosine kinasesignalingtotal internal reflection fluorescence microscopy

Identifiers

PMID36581204
PMCPMC9900515
OpenAlexW4313253669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.